Difference in Impact of CYP2C19 Polymorphism on Platelet Reactivity and Clinical Outcomes Between Acute Coronary Syndrome (ACS) and Stable Angina

被引:0
|
作者
Hokimoto, Seiji [1 ]
Akasaka, Tomonori [1 ]
Kaikita, Koichi [1 ]
Nakagawa, Kazuko [2 ]
Ogawa, Hisao [1 ]
机构
[1] Kumamoto Univ, Dept Cardiovasc Med, Kumamoto, Japan
[2] Kumamoto Univ, Div Pharmacol & Therapeut, Kumamoto, Japan
关键词
Acute coronary syndromes; Pharmacogenetics; Percutaneous coronary intervention; Genetics;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
16546
引用
收藏
页数:1
相关论文
共 50 条
  • [41] The impact of CYP2C19 and CYP4F2 variants and clinical factors on treatment outcomes during antiplatelet therapy
    Tatarunas, Vacis
    Kupstyte-Kristapone, Nora
    Norvilaite, Rita
    Tamakauskas, Vytenis
    Skipskis, Vilius
    Audrone, Veikutiene
    Jurgaityte, Julija
    Stuoka, Mantvydas
    Lesauskaite, Vaiva
    PHARMACOGENOMICS, 2019, 20 (07) : 483 - 492
  • [42] Clinical Impact of High on-Prasugrel Platelet Reactivity in an Acute Coronary Syndrome Population
    O'Connor, Stephen A.
    Kerneis, Mathieu
    Martin, Rejane
    Abtan, Jeremie
    Cayla, Guillaume
    Brugier, Delphine
    Barthelemy, Olivier
    Silvain, Johanne
    Vignalou, Jean-Baptiste
    Beygui, Farzin
    Collet, Jean-Philippe
    Montalescot, Gilles
    CIRCULATION, 2012, 126 (21)
  • [43] Comparison of loading with maintenance dose of clopidogrel on platelet reactivity in Chinese with different CYP2C19 genotypes prior to percutaneous coronary intervention
    Zhang Xiaoxing
    Yan Lirong
    Wang Dongxue
    Li Yan
    Han Lulu
    Tian Lei
    Liu Hong
    Li Yishi
    CHINESE MEDICAL JOURNAL, 2014, 127 (14) : 2571 - 2577
  • [44] The relationship between the CYP2C19*17 genetic polymorphism and the efficacy and safety of diazepam in patients with alcohol withdrawal syndrome
    Skryabin, V. Yu
    Zastrozhin, M. S.
    Grishina, E. A.
    Ryzhikova, K. A.
    Shipitsyn, V. V.
    Barna, I., V
    Galaktionova, T. E.
    Sorokin, A. S.
    Bryun, E. A.
    Sychev, D. A.
    BYULLETEN SIBIRSKOY MEDITSINY, 2019, 18 (04): : 119 - 126
  • [45] Relationship of CYP2C19*2 and CYP2C19*3 Gene Polymorphism with Clopidogrel Response Variability and Recurrent Cardiovascular Events in Chinese Patients Undergoing Percutaneous Coronary Intervention
    Liu, Yamin
    Liu, Naifeng
    Li, Weilan
    Shao, Hua
    Zhi, Hong
    Li, Jie
    PHARMACOLOGY, 2013, 91 (3-4) : 165 - 172
  • [46] Influence of Genetic Polymorphisms on Clopidogrel Response and Clinical Outcomes in Patients with Acute Ischemic Stroke CYP2C19 Genotype on Clopidogrel Response
    Han, Yan
    Lv, Hui-Hui
    Liu, Xu
    Dong, Qiang
    Yang, Xiao-Li
    Li, Shi-Xu
    Wu, Shuai
    Jiang, Jian-Ming
    Luo, Zheng
    Zhu, De-Sheng
    Zhang, Yi
    Zheng, Yi
    Guan, Yang-Tai
    Xu, Jian-Feng
    CNS NEUROSCIENCE & THERAPEUTICS, 2015, 21 (09) : 692 - 697
  • [47] Effect of CYP2C19 Genotype on Inhibition of Platelet Aggregation in Hemodialysis Patients With Coronary Artery Disease
    Waseda, Katsuhisa
    Saka, Yuki
    Takashima, Hiroaki
    Kurita, Akiyoshi
    Ando, Hirohiko
    Sakurai, Shinichiro
    Suzuki, Akihiro
    Sawada, Hiroaki
    Sato, Shigeko
    Nishikawa, Yoshinori
    Amano, Tetsuya
    CIRCULATION, 2016, 134
  • [48] Effect of CYP2C19 Genotype on Inhibition of Platelet Aggregation in Hemodialysis Patients With Coronary Artery Disease
    Waseda, Katsuhisa
    Saka, Yuki
    Takashima, Hiroaki
    Kurita, Akiyoshi
    Ando, Hirohiko
    Sakurai, Shinichiro
    Suzuki, Akihiro
    Sawada, Hiroaki
    Sato, Shigeko
    Nishikawa, Yoshinori
    Amano, Tetsuya
    CIRCULATION, 2016, 134
  • [49] Clinical Impact of CYP2C19 Genotype on Clopidogrel-Based Antiplatelet Therapy After Percutaneous Coronary Intervention
    Lee, Seung Hun
    Jeong, Young-Hoon
    Hong, David
    Choi, Ki Hong
    Lee, Joo Myung
    Park, Taek Kyu
    Yang, Jeong Hoon
    Hahn, Joo-Yong
    Choi, Seung-Hyuck
    Gwon, Hyeon-Cheol
    Jeong, Myung Ho
    Kim, Byeong-Keuk
    Joo, Hyung Joon
    Chang, Kiyuk
    Park, Yongwhi
    Ahn, Sung Gyun
    Suh, Jung-Won
    Lee, Sang Yeub
    Cho, Jung Rae
    Her, Ae-Young
    Kim, Hyo-Soo
    Kim, Moo Hyun
    Lim, Do-Sun
    Shin, Eun-Seok
    Song, Young Bin
    JACC-CARDIOVASCULAR INTERVENTIONS, 2023, 16 (07) : 829 - 843
  • [50] Effect of CYP2C19 genetic polymorphism on the pharmacodynamics and clinical outcomes for patients treated with ticagrelor: a systematic review with qualitative and quantitative meta-analysis
    Xie, Qiufen
    Xiang, Qian
    Liu, Zhiyan
    Mu, Guangyan
    Zhou, Shuang
    Zhang, Zhuo
    Ma, Lingyue
    Gong, Yanjun
    Jiang, Jie
    Cui, Yimin
    BMC CARDIOVASCULAR DISORDERS, 2022, 22 (01)